Form 8-K - Current report:
SEC Accession No. 0001062993-14-006111
Filing Date
2014-10-23
Accepted
2014-10-23 17:17:51
Documents
4
Period of Report
2014-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 12142
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 64892
3 EXHIBIT 10.2 exhibit10-2.htm EX-10.2 61856
4 EXHIBIT 10.3 exhibit10-3.htm EX-10.3 60980
  Complete submission text file 0001062993-14-006111.txt   201191
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-51652 | Film No.: 141170576
SIC: 8731 Services-Commercial Physical & Biological Research